Skip to main content

Table 1 Somatometric measurements and the results of 75-g oral glucose tolerance test and magnetic resonance imaging

From: Associations among the plasma amino acid profile, obesity, and glucose metabolism in Japanese adults with normal glucose tolerance

 

Overall (n = 83)

Obese (n = 10)

Nonobese (n = 73)

p values a

Visceral obesity (n = 18)

Nonvisceral obesity (n = 65)

p valuesb

Gender (male/female)

66/17

10/0

56/17

0.114

18/0

48/17

0.017

Age (years)

34.0 ± 5.7

35.2 ± 3.8

33.8 ± 5.9

0.487

37.1 ± 7.0

33.2 ± 5.0

0.009

Somatometric measurements

     

 Body weight (kg)

65.5 ± 9.9

79.5 ± 8.5

63.5 ± 8.5

<0.001

72.0 ± 8.2

63.7 ± 9.6

0.001

 Body mass index (kg/m2)

22.5 ± 2.4

26.7 ± 2.3

21.9 ± 1.8

<0.001

24.1 ± 2.6

22.0 ± 2.2

0.001

 Waist circumference (cm)

78.8 ± 7.2

88.9 ± 5.8

77.4 ± 6.2

<0.001

84.8 ± 6.7

77.2 ± 6.4

<0.001

 75 g-oral glucose tolerance test

       

 Fasting plasma glucose (mg/dl)

91.7 ± 8.1

100.7 ± 5.2

90.4 ± 7.6

<0.001

91.9 ± 9.4

91.6 ± 7.7

0.868

 2-h plasma glucose (mg/dl)

104.3 ± 16.1

110.3 ± 17.2

103.4 ± 15.9

0.209

108.1 ± 19.2

103.2 ± 15.1

0.255

 Insulin resistance (HOMA-IR)

1.2 ± 0.8

2.1 ± 1.6

1.1 ± 0.5

<0.001

1.5 ± 1.3

1.2 ± 0.6

0.067

 Insulin sensitivity (OGIS)

446.6 ± 47.1

394.0 ± 52.0

453.8 ± 41.8

<0.001

436.6 ± 65.4

449.4 ± 40.9

0.312

 Insulin secretion (HOMA-β)

71.3 ± 37.8

78.8 ± 53.6

70.3 ± 35.4

0.507

82.4 ± 45.7

68.2 ± 35.0

0.159

 Insulin secretion (II)c

0.3 ± 0.2

0.5 ± 0.4

0.3 ± 0.1

<0.001

0.4 ± 0.4

0.3 ± 0.1

0.004

Magnetic resonance imaging-derived fat area

     

 Visceral fat area (cm2)

77.1 ± 34.3

88.0 ± 39.2

75.6 ± 33.6

0.285

127.6 ± 27.1

63.1 ± 19.8

<0.001

 Subcutaneous fat area (cm2)

122.9 ± 42.5

176.8 ± 51.2

115.5 ± 35.6

<0.001

136.4 ± 43.5

119.2 ± 41.8

0.129

  1. Data are mean ± SD. obese: BMI ≥ 25, nonobese: BMI < 25; visceral obesity: visceral fat area ≥ 100 cm2, nonvisceral obesity: visceral fat area < 100 cm2
  2. HOMA-β, homeostasis model assessment for β-cell function index; HOMA-IR, homeostasis model assessment for insulin resistance; II, insulinogenic index; OGIS, oral glucose insulin sensitivity. aobese vs nonobese, bVisceral obesity vs Nonvisceral obesity, c n = 81 (Data set from 2 subjects were excluded due to unphysiological glucose/insulin levels. Bold numbers indicate significant differences between the two groups with p <0.05